Literature DB >> 23973862

Redox-sensitive glycogen synthase kinase 3β-directed control of mitochondrial permeability transition: rheostatic regulation of acute kidney injury.

Zhen Wang1, Yan Ge2, Hui Bao1, Lance Dworkin2, Ai Peng3, Rujun Gong4.   

Abstract

Mitochondrial dysfunction plays a pivotal role in necroapoptotic cell death and in the development of acute kidney injury (AKI). Evidence suggests that glycogen synthase kinase (GSK) 3β resides at the nexus of multiple signaling pathways implicated in the regulation of mitochondrial permeability transition (MPT). In cultured renal tubular epithelial cells, a discrete pool of GSK3β was detected in mitochondria. Coimmunoprecipitation assay confirmed that GSK3β physically interacts with cyclophilin F and voltage-dependent anion channel (VDAC), key MPT regulators that possess multiple GSK3β phosphorylation consensus motifs, suggesting that GSK3β has a direct control of MPT. Upon a strong burst of reactive oxygen species elicited by the pro-oxidant herbicide paraquat, the activity of the redox-sensitive GSK3β was drastically enhanced. This was accompanied by augmented phosphorylation of cyclophilin F and VDAC, associated with MPT and cell death. Inhibition of GSK3β by either the selective inhibitor 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) or forced expression of a kinase-dead mutant obliterated paraquat-induced phosphorylation of cyclophilin F and VDAC, prevented MPT, and improved cellular viability. Conversely, ectopic expression of a constitutively active GSK3β amplified the effect of paraquat on cyclophilin F and VDAC phosphorylation and sensitized cells to paraquat-induced MPT and death. In vivo, paraquat injection elicited marked oxidant stress in the kidney and resulted in acute kidney dysfunction and massive tubular apoptosis and necrosis. Consistent with in vitro findings, the activity of GSK3β was augmented in the kidney after paraquat injury, associated with increased phosphorylation of cyclophilin F and VDAC and sensitized MPT. TDZD-8 blocked GSK3β activity in the kidney, intercepted cyclophilin F and VDAC phosphorylation, prevented MPT, attenuated tubular cell death, and ameliorated paraquat-induced AKI. Our data suggest that the redox-sensitive GSK3β regulates renal tubular injury in AKI by controlling the activity of MPT regulators.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Cyclophilin F; Free radicals; Glycogen synthase kinase 3β; Mitochondrial permeability transition; Paraquat; Voltage-dependent anion channel

Mesh:

Substances:

Year:  2013        PMID: 23973862      PMCID: PMC3859848          DOI: 10.1016/j.freeradbiomed.2013.08.169

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  67 in total

1.  Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.

Authors:  Ali C M Johnson; Kirsten Becker; Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-26

2.  GSK3beta plays dirty in acute kidney injury.

Authors:  Peter J Nelson; Lloyd Cantley
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

Review 3.  Mitochondria as decision-makers in cell death.

Authors:  Vilmante Borutaite
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

Review 4.  Cyclophilin D in mitochondrial pathophysiology.

Authors:  Valentina Giorgio; Maria Eugenia Soriano; Emy Basso; Elena Bisetto; Giovanna Lippe; Michael A Forte; Paolo Bernardi
Journal:  Biochim Biophys Acta       Date:  2009-12-21

5.  Conditional ablation of glycogen synthase kinase 3β in postnatal mouse kidney.

Authors:  Yan Ge; Jin Si; Li Tian; Shougang Zhuang; Lance D Dworkin; Rujun Gong
Journal:  Lab Invest       Date:  2010-08-02       Impact factor: 5.662

6.  Protective effect of sulforaphane against cisplatin-induced mitochondrial alterations and impairment in the activity of NAD(P)H: quinone oxidoreductase 1 and γ glutamyl cysteine ligase: studies in mitochondria isolated from rat kidney and in LLC-PK1 cells.

Authors:  Carlos Enrique Guerrero-Beltrán; Mariel Calderón-Oliver; Eduardo Martínez-Abundis; Edilia Tapia; Guillermo Zarco-Márquez; Cecilia Zazueta; José Pedraza-Chaverri
Journal:  Toxicol Lett       Date:  2010-08-21       Impact factor: 4.372

7.  Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure.

Authors:  Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Silvia Lores-Arnaiz; Juanita Bustamante
Journal:  Neurochem Res       Date:  2010-06-01       Impact factor: 3.996

Review 8.  Mitochondria, reactive oxygen species and cadmium toxicity in the kidney.

Authors:  Glenda Gobe; Denis Crane
Journal:  Toxicol Lett       Date:  2010-04-22       Impact factor: 4.372

9.  GSK3beta promotes apoptosis after renal ischemic injury.

Authors:  Zhiyong Wang; Andrea Havasi; Jonathan Gall; Ramon Bonegio; Zhijian Li; Haiping Mao; John H Schwartz; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

10.  Forty percent methionine restriction decreases mitochondrial oxygen radical production and leak at complex I during forward electron flow and lowers oxidative damage to proteins and mitochondrial DNA in rat kidney and brain mitochondria.

Authors:  Pilar Caro; Jose Gomez; Ines Sanchez; Alba Naudi; Victoria Ayala; Monica López-Torres; Reinald Pamplona; Gustavo Barja
Journal:  Rejuvenation Res       Date:  2009-12       Impact factor: 4.663

View more
  27 in total

Review 1.  Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Authors:  Zhangsuo Liu; Rujun Gong
Journal:  Am J Kidney Dis       Date:  2015-08-10       Impact factor: 8.860

2.  Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.

Authors:  Zhen Wang; Hui Bao; Yan Ge; Shougang Zhuang; Ai Peng; Rujun Gong
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 3.  Glycogen Synthase Kinase-3 Signaling in Acute Kidney Injury.

Authors:  Abeda Jamadar; Reena Rao
Journal:  Nephron       Date:  2020-07-29       Impact factor: 2.847

4.  Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2).

Authors:  Masaya Tanno; Atsushi Kuno; Satoko Ishikawa; Takayuki Miki; Hidemichi Kouzu; Toshiyuki Yano; Hiromichi Murase; Toshiyuki Tobisawa; Makoto Ogasawara; Yoshiyuki Horio; Tetsuji Miura
Journal:  J Biol Chem       Date:  2014-09-03       Impact factor: 5.157

5.  Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.

Authors:  Weiwei Xu; Yan Ge; Zhihong Liu; Rujun Gong
Journal:  Am J Pathol       Date:  2014-10       Impact factor: 4.307

Review 6.  Mitochondria Damage and Kidney Disease.

Authors:  Pu Duann; Pei-Hui Lin
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.

Authors:  Weiwei Xu; Yan Ge; Zhihong Liu; Rujun Gong
Journal:  J Biol Chem       Date:  2014-12-02       Impact factor: 5.157

Review 8.  Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.

Authors:  Andrew S Brem; Rujun Gong
Journal:  Clin Sci (Lond)       Date:  2015-05       Impact factor: 6.124

Review 9.  Lithium in the Kidney: Friend and Foe?

Authors:  Mohammad Alsady; Ruben Baumgarten; Peter M T Deen; Theun de Groot
Journal:  J Am Soc Nephrol       Date:  2015-11-17       Impact factor: 10.121

10.  Glycogen synthase kinase-3β inhibits tubular regeneration in acute kidney injury by a FoxM1-dependent mechanism.

Authors:  Sonali Sinha; Nidhi Dwivedi; James Woodgett; Shixin Tao; Christianna Howard; Timothy A Fields; Abeda Jamadar; Reena Rao
Journal:  FASEB J       Date:  2020-08-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.